Cocrystal Pharma
IPOPublic · $48.7M raised
- Website
- cocrystalpharma.com
- Total Funding
- $48.7M
- Last Round
- $1.0M Private EquityOct 2025
- Rounds
- 4
- Type
- Public
- Ticker
- COCP · NASDAQ
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Cocrystal Pharma is a clinical-stage biotechnology company discovering and developing broad-spectrum antiviral therapeutics that target viral replication. Its programs address influenza, coronaviruses, norovirus, hepatitis C, rhinovirus, and related serious or chronic viral diseases. The company applies structure-based technologies and specialist scientific expertise to create potential first- and best-in-class antiviral drugs, with candidates progressing through discovery, preclinical, and clinical development.
Summary
Cocrystal Pharma is a Biotech company. It has raised $48.7M in total across 4 rounds, most recently a $1.0M Private Equity round in Oct 2025.
Funding History
Oct 2025
Sign up to see all 4 events
Funding: Private Equity. Amounts, valuations, and investors where available.
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cocrystal-pharma"><img src="https://indexed.vc/api/badge/company/cocrystal-pharma" alt="Cocrystal Pharma on Indexed.vc" width="260" height="76" /></a>